Clinical Trial Update: Efficacy of Artemisia Pollen Specific Allergen Immunotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of Artemisia pollen-specific allergen immunotherapy for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Artemisia pollen-specific allergen immunotherapy

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Allergic Rhinitis | Phase 4 | Status: UNKNOWN